Physician profile
Sunil Patel
NPI 1801987565
$6,735.43
in general payments reported to CMS, 2019-2025
36 companies · $232 in 2025
The $232 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,180 · 2020: $741 · 2021: $395 · 2022: $1,217 · 2023: $1,699 · 2024: $272 · 2025: $232.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,203.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,203.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $1,208.40 | 2019-2024 | Mounjaro, Jardiance, Emgality |
| Glaxosmithkline, LLC. | $826.33 | 2019-2023 | Trelegy Ellipta, Shingrix, Arexvy |
| Novo Nordisk INC | $548.52 | 2019-2024 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $470.26 | 2019-2024 | Farxiga, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $437.95 | 2019-2023 | Jardiance, Spiriva Respimat, Stiolto Respimat |
| Pfizer INC. | $427.06 | 2019-2025 | |
| Abbvie INC. | $420.53 | 2020-2023 | |
| Sanofi-Aventis U.S. LLC | $283.64 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $273.98 | 2019-2023 | Vaxneuvance, Proquad, Vaxelis |
| Novartis Pharmaceuticals Corporation | $273.12 | 2019-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $266.14 | 2019-2024 | Xifaxan |
| Amgen INC. | $225.30 | 2019-2023 | Prolia, Evenity |
| Surmodics, INC. | $146.03 | 2024 | Pounce Venous Thrombectomy System, Pounce LP Thrombectomy, Pounce Thrombectomy |
| Horizon Therapeutics Plc | $125.00 | 2023 | Krystexxa |
| Dynavax Technologies Corporation | $81.13 | 2021-2023 | Heplisav-B |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $63.62 | 2025 | Sapien 3 Ultra Resilia |
| Janssen Pharmaceuticals, INC | $62.27 | 2019-2023 | Xarelto |
| Ultragenyx Pharmaceutical INC. | $61.89 | 2020-2023 | |
| Stryker Corporation | $54.97 | 2025 | Artix Mt |
| Phadia US INC. | $53.28 | 2019-2022 | |
| Boston Scientific Corporation | $49.19 | 2025 | Ekosonic |
| Bayer Healthcare Pharmaceuticals INC. | $46.54 | 2023 | |
| Corcept Therapeutics | $42.61 | 2019 | |
| Alkermes, INC. | $35.75 | 2025 | Aristada, Lybalvi |
| Abbott Laboratories | $34.56 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $30.79 | 2020-2022 | |
| Amarin Pharma, INC. | $28.48 | 2020-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $25.56 | 2019-2023 | Trintellix |
| Teva Pharmaceuticals USA, INC. | $23.96 | 2021 | |
| Sunovion Pharmaceuticals INC. | $23.30 | 2019 | |
| Philips North America LLC | $20.02 | 2023 | |
| Gilead Sciences, INC. | $19.10 | 2019 | |
| Exact Sciences Corporation | $17.79 | 2023 | Cologuard Collection Kit |
| Mylan Specialty L.P. | $17.29 | 2019 | |
| Hikma Pharmaceuticals USA | $11.07 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sunil Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.